{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:26:20Z","timestamp":1767911180708,"version":"3.49.0"},"reference-count":43,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Aiding Project for Introduction of Overseas Students in Hebei Province 2018","award":["C201853"],"award-info":[{"award-number":["C201853"]}]},{"name":"Key R&D Plan Project of Hebei Science and Technology Department","award":["18277798D"],"award-info":[{"award-number":["18277798D"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Orthopaedic Surgery"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of this retrospective study was to evaluate the clinical and oncological results of combination treatment of short\u2010term preoperative denosumab (the receptor activator of nuclear factor kappa\u2010B ligand inhibitor) with surgery in unresectable or recurrent cases of giant cell tumor of the bone (GCTB).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between 2016 and 2018, 11 eligible patients (1 man, 10 women, mean age 38.1\u2009years) with grade 3 GCTB were treated with a combination of short\u2010term (six doses) preoperative denosumab and surgery in a single institution. The clinical, radiological, and pathological alteration after the denosumab treatment were compared. The oncological results of the combination therapy were also recorded. Meanwhile, adverse effects or complications of denosumab, if any, were reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median follow\u2010up time after surgical procedure was 30\u2009months (range 13\u201345\u2009months). After 3\u20134 denosumab injections, pain relief was observed in all patients. In two spine patients, the neurological status improved after four doses of treatment. Intraoperatively, the margin of the tumor became clear and the intensity of the tumor increased while the blood supply around and within the lesion decreased. Within the lesion, the typically soft and loose tissue were replaced by the tough and dense fibro\u2010osseous tissue. The mean diameter of the lesion before and after treatment was 61.55 \u00b1\u200922.49\u2009mm and 51.81 \u00b1\u200921.12\u2009mm, respectively, and the T\u2010score was 1.02 (<jats:italic>P<\/jats:italic> =\u20090.32). Variable calcification was observed at the periphery and within the lesion. A total of three patients experienced local recurrence in this study. In the resection group, only one extremity patient had soft tissue recurrence that was treated with en\u2010bloc excision. In the curettage group, two of three sacral tumor patients had local occurrence. Both refused re\u2010operation and restarted the monthly denosumab injection thereafter, and the lesions remained stable at the final follow up. Finally, no adverse effects or complications related to denosumab treatment were found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For the unresectable or recurrent GCTB cases, short\u2010term (six doses) preoperative use of denosumab improved clinical symptoms, decreased the tumor size, and increased the tumor density. The changes in tumors, in turn, simplified the tumor removal manipulation and, subsequently, decreased the local recurrence for the resection surgery. For the curettage, the denosumab\u2010induced changes had mixed impacts, and shorter term (fewer than six doses) usage may be more appropriate. Our six\u2010dose regime was deemed safe, while the safety of long\u2010term use remains unknown.<\/jats:p><\/jats:sec>","DOI":"10.1111\/os.12561","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T08:41:50Z","timestamp":1574671310000},"page":"1101-1108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Short\u2010term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone"],"prefix":"10.1111","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-0829","authenticated-orcid":false,"given":"Run\u2010zi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Orthopaedics and Traumatology, Faculty of Medicine The Chinese University of Hong Kong  Shatin Hong Kong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian\u2010xiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Tumor, Key Biomechanical Laboratory of Orthopaedics Third Hospital of Hebei Medical University  Shijiazhuang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian\u2010wen","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Tumor, Key Biomechanical Laboratory of Orthopaedics Third Hospital of Hebei Medical University  Shijiazhuang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Tumor, Key Biomechanical Laboratory of Orthopaedics Third Hospital of Hebei Medical University  Shijiazhuang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongyu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Tumor, Key Biomechanical Laboratory of Orthopaedics Third Hospital of Hebei Medical University  Shijiazhuang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo\u2010chuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Musculoskeletal Tumor, Key Biomechanical Laboratory of Orthopaedics Third Hospital of Hebei Medical University  Shijiazhuang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999.0000000000000243"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/os.12242"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.16.00072"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.94"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-014-1268-5"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-016-1034-y"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13569-016-0056-0"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv307"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/os.12336"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007799"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3182568fb6"},{"key":"e_1_2_7_13_1","first-page":"2069","article-title":"Radiotherapy for giant cell tumors of the bone: a safe and effective treatment modality","volume":"32","author":"Kriz J","year":"2012","journal-title":"Anticancer Res"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.M.01332"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.03.020"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1478-3"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70277-8"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-017-3536-9"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148401"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70010-3"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.028"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1278305"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100217"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-198769010-00018"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0017"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999.0000000000000104"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.17.00057"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-0907.R2"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4634-9"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2015.10.045"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-015-4348-5"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000001191"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-2190-6"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.blo.0000128643.38390.07"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/os.12174"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-017-5505-4"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aott.2016.03.004"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203248"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2017.1389473"},{"key":"e_1_2_7_40_1","first-page":"36","article-title":"Osteonecrosis of the jaw in patients receiving bone\u2010targeted therapies: an overview\u2013part I","volume":"111","author":"Turner B","year":"2016","journal-title":"Urol Nurs"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2684924"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr435"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/767198"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-015-4249-2"}],"container-title":["Orthopaedic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fos.12561","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/os.12561","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/os.12561","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/os.12561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T13:53:34Z","timestamp":1694181214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/os.12561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["10.1111\/os.12561"],"URL":"https:\/\/doi.org\/10.1111\/os.12561","archive":["Portico"],"relation":{},"ISSN":["1757-7853","1757-7861"],"issn-type":[{"value":"1757-7853","type":"print"},{"value":"1757-7861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"2019-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}